Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Brain Stimulation|June 18, 2013
The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the double-blind phase of the OPT-TMS TrialJeffrey J Borckardt, Ziad H Nahas, John Teal, et al.Depression and Anxiety|September 8, 2011
Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depressionWilliam M McDonald, Valerie Durkalski, Edward R Ball, et al.Archives of General Psychiatry|May 5, 2010
Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trialMark S George, Sarah H Lisanby, David Avery, et al.Journal of Consulting and Clinical Psychology|May 21, 2014
Types of parental involvement in CBT with anxious youth: a preliminary meta-analysisKatharina Manassis, Trevor Changgun Lee, Kathryn Bennett, et al.Transfusion|September 29, 2020
Provision of COVID-19 Convalescent Plasma in a Resource-Constrained StateTina S Ipe, Tuan Le, Brian Quinn, et al.Depression and Anxiety|May 10, 2013
Cognitive behavioral therapy age effects in child and adolescent anxiety: an individual patient data metaanalysisKathryn Bennett, Katharina Manassis, Stephen D Walter, et al.Brain Stimulation|April 3, 2012
Prefrontal rTMS for treating depression: location and intensity results from the OPT-TMS multi-site clinical trialKevin A Johnson, Mirza Baig, Dave Ramsey, et al.Biological Psychiatry|June 19, 2007
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trialJohn P O'Reardon, H Brent Solvason, Philip G Janicak, et al.ACS Nano|August 9, 2013
A multi-stakeholder perspective on the use of alternative test strategies for nanomaterial safety assessmentAndre E Nel, Elina Nasser, Hilary Godwin, et al.ACS Nano|March 21, 2015
Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-makingHilary Godwin, Catherine Nameth, David Avery, et al.Pageof 8